These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8860933)

  • 1. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease.
    Shea JJ; Ge X
    Otolaryngol Clin North Am; 1996 Apr; 29(2):353-8. PubMed ID: 8860933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease.
    Shea JJ
    Otolaryngol Clin North Am; 1997 Dec; 30(6):1051-9. PubMed ID: 9386241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
    Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
    Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Menière's disease.
    Shea JJ
    Am J Otol; 1993 May; 14(3):224-9. PubMed ID: 8372918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptomycin perfusion of the labyrinth through the round window plus intravenous streptomycin.
    Shea JJ; Ge X
    Otolaryngol Clin North Am; 1994 Apr; 27(2):317-24. PubMed ID: 8022611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF; Richey PA; Wan JY; Stevens SR
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
    Kitahara T; Kubo T; Okumura S; Kitahara M
    Laryngoscope; 2008 May; 118(5):854-61. PubMed ID: 18520184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report).
    Silverstein H; Choo D; Rosenberg SI; Kuhn J; Seidman M; Stein I
    Ear Nose Throat J; 1996 Aug; 75(8):468-71, 474, 476 passim. PubMed ID: 8828271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptomycin perfusion of the labyrinth.
    Shea JJ; Norris CH
    Acta Otolaryngol Suppl; 1991; 485():123-30. PubMed ID: 1843164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effect of streptomycin perfusion of the labyrinth in the treatment of Meniere's disease and endolymphatic hydrops].
    Peng AQ; Lu YD; Ren JH; Chen Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 14(10):438-9. PubMed ID: 12563709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing results with streptomycin perfusion of the labyrinth.
    Shea JJ; Ge X
    Am J Otol; 1993 Nov; 14(6):570-5. PubMed ID: 8296861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion of the inner ear with streptomycin.
    Shea JJ
    Am J Otol; 1989 Mar; 10(2):150-5. PubMed ID: 2735389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone inner ear perfusion for subclinical endolymphatic hydrops.
    Silverstein H; Farrugia M; Van Ess M
    Ear Nose Throat J; 2009 Feb; 88(2):778-85. PubMed ID: 19224478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain and inner-ear fluid homeostasis, cochleovestibular-type tinnitus, and secondary endolymphatic hydrops.
    Shulman A; Goldstein B
    Int Tinnitus J; 2006; 12(1):75-81. PubMed ID: 17147045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of fluctuant hearing loss.
    Shea JJ
    Otolaryngol Clin North Am; 1975 Jun; 8(2):263-6. PubMed ID: 1153194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of hearing loss in Meniere's disease.
    Grant IL; Welling DB
    Otolaryngol Clin North Am; 1997 Dec; 30(6):1123-44. PubMed ID: 9386248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The endolymphatic sac: its roles in the inner ear].
    Couloigner V; Teixeira M; Sterkers O; Rask-Andersen H; Ferrary E
    Med Sci (Paris); 2004 Mar; 20(3):304-10. PubMed ID: 15067575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporins as potential drug targets for Meniere's disease and its related diseases.
    Takeda T; Taguchi D
    Handb Exp Pharmacol; 2009; (190):171-84. PubMed ID: 19096777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.